MindBio Therapeutics (MBIO)

PRESS RELEASE

published on 04/30/2024 at 12:05, 6 months 23 days ago

MindBio Therapeutics Announces Landmark Women’s Health CNS Drug Trials
MindBio Therapeutics Corp. announces world first clinical trials in women's health using MB22001, a proprietary form of LSD for PMS treatment

Clinical Trials MindBio Therapeutics Corp. MB22001 Women's Health PMS Treatment
BRIEF

published on 04/23/2024 at 06:25, 7 months 1 day ago

MindBio Therapeutics Publishes Sleep Research in Translational Psychiatry

MB22001 Microdosing MindBio Therapeutics Sleep Research Depressive Disorders
BRIEF

published on 04/23/2024 at 06:25, 7 months 1 day ago

MindBio Therapeutics publie des recherches sur le sommeil en psychiatrie translationnelle

MB22001 Microdosage MindBio Thérapeutique Recherche Sur Le Sommeil Troubles Dépressifs
PRESS RELEASE

published on 04/23/2024 at 06:20, 7 months 1 day ago

MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
La recherche sur le sommeil du scientifique de MindBio publiée dans une prestigieuse revue scientifique évaluée par des pairs. L'étude porte sur l'utilisation du protocole de traitement propriétaire de MindBio avec MB22001 pour un sommeil plus long et de meilleure qualité après microdosing

Depression MB22001 Traitement MindBio Psychiatrie
PRESS RELEASE

published on 04/23/2024 at 06:20, 7 months 1 day ago

MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
MindBio's sleep research using MB22001 published in Nature's Translational Psychiatry journal. Research indicates improved sleep quality & duration after microdosing, advancing treatment for depressive disorders globally

MindBio Therapeutics Corp. MB22001 Microdosing Sleep Research Depressive Disorders
BRIEF

published on 04/16/2024 at 12:45, 7 months 7 days ago

MindBio Therapeutics annonce une demande de conversion d'actions de Riverfort Global Opportunities

MindBio Thérapeutique Actualités Financières Loi Sur Les Valeurs Mobilières Conversion D'actions Opportunités Mondiales De Riverfort
BRIEF

published on 04/16/2024 at 12:45, 7 months 7 days ago

MindBio Therapeutics Announces Share Conversion Request by Riverfort Global Opportunities

Financial News Share Conversion MindBio Therapeutics Securities Law Riverfort Global Opportunities
PRESS RELEASE

published on 04/16/2024 at 12:40, 7 months 7 days ago

Lender Requests to Convert Loan to MindBio Shares
MindBio Therapeutics Corp. announces conversion of loan to shares at $0.05 per Share. Shares subject to 4-month hold period. Company focuses on mental health treatments and microdosing LSD clinical trials

Clinical Trials MindBio Therapeutics Corp. Microdosing LSD Loan Conversion Mental Health Treatments
BRIEF

published on 03/20/2024 at 09:55, 8 months 3 days ago

MindBio Therapeutics passe à l'essai clinique de phase 2B dans le trouble dépressif majeur avec MB22001

Depression MB22001 Essai Clinique MindBio Thérapeutique Médecine Psychédélique
BRIEF

published on 03/20/2024 at 09:55, 8 months 3 days ago

MindBio Therapeutics Advances to Phase 2B Clinical Trial in Major Depressive Disorder with MB22001

Psychedelic Medicine MB22001 Clinical Trial MindBio Therapeutics Depressive Disorder

Published on 11/22/2024 at 23:55, 1 day 8 hours ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 8 hours ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 9 hours ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day 9 hours ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 9 hours ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 13 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 14 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 14 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 15 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 16 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 17:45, 1 day 14 hours ago

IMMERSION : RFA 2023/2024
Published on 11/22/2024 at 16:15, 1 day 15 hours ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 1 day 17 hours ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 1 day 17 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 3 days 1 hour ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE

News